AMP v. Myriad Genetics: Gene Patents, Patenting Life, and the Impact on U.S. Stem Cell Research
June 10, 2013 | Kirstin R.W. Matthews, Maude Rowland Cuchiara

Table of Contents
Author(s)
Kirstin R.W. Matthews
Fellow in Science and Technology PolicyMaude Rowland Cuchiara
Nonresident ScholarThis poster presentation by the Science and Technology Policy Program describes the progression of the Association for Molecular Pathology v. Myriad Genetics court case, which addresses gene patenting.